Renal Research Institute
New York, 10065, United States
NCT Number: NCT02501044
Hemodialysis patients may experience drops in blood oxygen saturation during the hemodialysis treatment, which may lead to hypoxia in the tissues.
The investigators hypothesize that:
1. The cumulative number, severity, or other characteristics of such deoxygenation episodes may be a predictor of adverse outcomes in hemodialysis patients. 2. There may be demographic, anthropometric, clinical, treatment prescription, lab analytical, and other parameters that correlate with the number and severity of deoxygenation episodes and, therefore, may be used for risk stratification. Further, some of these parameters may be modifiable.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
New York, 10065, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Time frame: Up to 36 months
Crit-Line III monitor recordings (which contain oxygen saturation data) will be extracted from the RRI database and the cumulative number of deoxygenation episodes will be analyzed.
Renal Research Institute
Other
Oxygen Desaturation During Hemodialysis: Clinical Correlates and Association With Adverse Outcomes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03242343
Aneurysm, Arterio-venous Fistula
Birmingham, Alabama, United States
View Trial DetailsNCT05700903
Androgen Deprivation Therapy, Autonomic Dysfunction
Aurora, Colorado, United States
View Trial DetailsNCT06614712
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Seville, Spain
View Trial DetailsNCT04380610
Anemia, Anemia, Hemolytic
Birmingham, Alabama, United States
View Trial Details